OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Facial Numbness, Dysarthria, Muscle Atrophy, and Weakness in a Young Patient	451
Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis	408
Diplopia and Ptosis in an Older Woman	363
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	345
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	316
Early Posttraumatic Seizures—Putting Things in Perspective	306
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	258
Error in Author Name	238
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	231
Origin of Transthyretin in Cerebral Amyloid Angiopathy	212
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	198
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up	196
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	189
Somebody to Love	187
Equipping AI for Unbiased and Inclusive Neurology	185
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	182
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis	182
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	182
Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study	181
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	177
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	175
Automated Imaging Differentiation for Parkinsonism	173
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	167
JAMA Neurology	164
The Neurologist’s Imperative in Brain Death	158

Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	155
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	149
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	146
Is It Really Itching?	145
JAMA Neurology	145
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	138
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	137
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	133
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome	129
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	127
Time to Change the Current Clinical Classification of Multiple Sclerosis?	124
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	123
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	121
Advanced Practice Clinicians—Neurology’s Underused Resource	120
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	116
Error in Abstract	112
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	110
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	108
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	108
Methylphenidate for Apathy in Alzheimer Disease—Why Should We Care?	108
Do Neurologists Need a Goldwater Rule?	108
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	107
Error in Figure	106
Histologic Anatomy of Neurocysticercosis	103
Error in Additional Contributions	97
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	96
Sleep Recording for the Diagnosis and Treatment of Paraplegia	93
Is It Really Itching?—Reply	93
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	91
JAMA Neurology	89
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	88
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	87
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	87
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	87
Error in Figure	85
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	85
Visual Neglect After an Isolated Lesion of the Superior Colliculus	85
Role of the X Chromosome in Alzheimer Disease Genetics	84
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	83
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	82
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	81
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	81
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	77
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	76
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	76
JAMA Neurology	75
Acute Myelopathy in a Man With Cutaneous Papules	75
Magnetic Resonance Imaging Features of GABA-A Receptor Antibody-Mediated Encephalitis	74
JAMA Neurology	74